
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Anti-angiogenic biomolecules in neovascular age-related macular degeneration; therapeutics and drug delivery systems
Mir Salar Kazemi, Alireza Shoari, Neda Salehibakhsh, et al.
International Journal of Pharmaceutics (2024) Vol. 659, pp. 124258-124258
Closed Access | Times Cited: 4
Mir Salar Kazemi, Alireza Shoari, Neda Salehibakhsh, et al.
International Journal of Pharmaceutics (2024) Vol. 659, pp. 124258-124258
Closed Access | Times Cited: 4
Showing 4 citing articles:
Excipients for Cerium Dioxide Nanoparticle Stabilization in the Perspective of Biomedical Applications
Svetlana A. Titova, Maria Petrovna Kruglova, Stupin Va, et al.
Molecules (2025) Vol. 30, Iss. 6, pp. 1210-1210
Open Access
Svetlana A. Titova, Maria Petrovna Kruglova, Stupin Va, et al.
Molecules (2025) Vol. 30, Iss. 6, pp. 1210-1210
Open Access
The 20th Anniversary of Pegaptanib (MacugenTM), the First Approved Aptamer Medicine: History, Recent Advances and Future Prospects of Aptamers in Therapy
Miklós Bege, Rasha Ghanem Kattoub, Anikó Borbás
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 394-394
Open Access
Miklós Bege, Rasha Ghanem Kattoub, Anikó Borbás
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 394-394
Open Access
Advances in Nanomedicine for Retinal Drug Delivery: Overcoming Barriers and Enhancing Therapeutic Outcomes
Pratikeswar Panda, Sanjib Mohanty, Sangita Ranee Gouda, et al.
Journal of drug targeting (2024), pp. 1-49
Closed Access | Times Cited: 1
Pratikeswar Panda, Sanjib Mohanty, Sangita Ranee Gouda, et al.
Journal of drug targeting (2024), pp. 1-49
Closed Access | Times Cited: 1
The Aryl Hydrocarbon Receptor: A Crucial Mediator in Ocular Disease Pathogenesis and Therapeutic Targeting
Juanjuan Ji, Chunyue Xiong, Huining Yang, et al.
Experimental Eye Research (2024) Vol. 249, pp. 110144-110144
Closed Access
Juanjuan Ji, Chunyue Xiong, Huining Yang, et al.
Experimental Eye Research (2024) Vol. 249, pp. 110144-110144
Closed Access